πŸ‡ΊπŸ‡Έ FDA
Patent

US 10829460

[6,6] fused bicyclic HDAC8 inhibitors

granted A61PA61P29/00A61P35/00

Quick answer

US patent 10829460 ([6,6] fused bicyclic HDAC8 inhibitors) held by Valo Early Discovery, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00, A61P35/00, A61P37/00